Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment.
This review focuses on the possible roles of phytocannabinoids, synthetic cannabinoids, endocannabinoids, and transient receptor potential cation channel, subfamily V, member 1 (TRPV1) channel blockers in epilepsy treatment. The phytocannabinoids are compounds produced by the herb Cannabis sativa, from which Δ